Valuation (34%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -1.02 | 31.84 |
PEG Ratio (TTM) | 0.07 | 8.92 |
P/S Ratio (TTM) | 1.15 | 4.69 |
P/B Ratio (TTM) | 0.94 | 9.71 |
P/FCF Ratio (TTM) | -2.09 | 30.80 |
Price to 5YR AVG Earnings Ratio | -0.74 | 65.39 |
Price to 5YR AVG FCF Ratio | -2.04 | 52.33 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -36.74% | 6.18% |
ROE (TTM) | -76.04% | 27.26% |
Net Profit Margin (TTM) | -69.75% | 2.70% |
ROIC 5YR AVG | -33.60% | 4.38% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -30.28% | -7,616.76% | -4,554.99% |
Revenue | -13.39% | 38.99% | 23.41% |
Net Income | -31.10% | -8,257.00% | -4,951.76% |
Cash Flow | -76.33% | -50.17% | -30.48% |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.66 | 2.32 |
Quick Ratio (TTM) | 1.62 | 1.77 |
D/E Ratio (TTM) | 0.54 | 1.14 |
Interest Coverage (TTM) | -15.32 | 7.87 |
Piotroski F-Score | 3 | 6 |
Altman Z-Score | N/A | 5.08 |
LTL to 5YR AVG FCF | -1.30 | 5.10 |
Shares Outstanding Growth 5YR AVG | 25.08% | 12.48% |